In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Biomat USA Inc.

Division of Probitas Pharma SA

Latest From Biomat USA Inc.

Deal Statistics Quarterly, Q3 2001

In Vivo presents another installment of our quarterly review of dealmaking--in this case July 2001-September 2001. Our data come from Windhover's Strategic Transactions Database. We include medical device financings by deal type; diagnostic financings by industry segment; pharma and biotech alliances by therapeutic category and industry segment; pharma and biotech financings by market segment, and pharma and biotech M&A.
BioPharmaceutical Medical Device
See All

Company Information

  • Industry
  • Biotechnology
  • Pharmaceuticals
  • Therapeutic Areas
  • Infectious & Viral Diseases
  • Alias(es)
  • SeraCare Inc.
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Probitas Pharma SA
  • Senior Management
  • Barry Plost, Chmn., Pres. & CEO
  • Contact Info
  • Biomat USA Inc.
    Phone: (310) 772-7777
    1925 Century Park East
    Suite 1970
    Los Angeles, CA 90067
    USA
Advertisement
Advertisement
UsernamePublicRestriction

Register